Strategic Analysis of the Global Omega-3 Pharmaceutical Market

Growing Consumer Need and Regulatory Friendliness Drive Market Growth

Regular Price: USD 2,450.00

Special Price USD 2,082.50

15% OFF

* Required Fields

Regular Price: USD 2,450.00

Special Price USD 2,082.50


Be the first to review this product

This research service provides strategic insights into omega-3 fatty acid in pharmaceutical applications. The global omega-3 pharmaceutical market is emerging and presents immense potential. Omega-3 supplied as dietary supplements are formulated with less than 50% of EPA and DHA, causing a deficit in nutritional balance and eventually leading to more capsule consumption per day. Inadequate omega-3 dosage in dietary supplements has turned consumers towards pharmaceutical omega-3, resulting in high demand. Consumers increasingly prefer high-concentrated omega-3, as it reduces the dosage and the number of capsules required per day. In this study, the base year is 2012 and the forecast runs from 2013-2016.

Table of Contents

Strategic Analysis of the Global Omega-3 Pharmaceutical Market, Global Omega-3 for Pharmaceutical Market AnalysisGlobal Omega-3 for Pharmaceutical ApplicationsOverview

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.